Unit 1 Flashcards

(80 cards)

1
Q

What is the biosynthetic pathways for production of prostaglandins, prostacyclin, thromboxane, and leukotrienes?

A

Arachidonic acid –> Prostaglandins + Leukotrienes

Enzyme for leukotriene formation: 5-lipoxygenase

Cyclooxygenase (COX-1 and COX-2) –> Prostaglandins + Prostacyclin (PGI2, from endothelial cells) + Thromboxane A2 (TXA2, from platelets)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the source of the precursor arachidonic acid and what are the specific enzymes involved?

A

Cell membrane phospholipids –> arachidonic acid

Enzyme = phospholipase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

COX-1: tissue locations, physiologic role, inhibitors?

A

Tissue locations: GI tract, platelets, kidneys, vascular smooth muscle

Physiologic role:
o GI TRACT: ↓ acid/pepsin secretions, ↑ mucus/bicarb production (cytoprotective effects)
o PLATELETS: Pro-aggregatory effect
o KIDNEYS: ↑ renal blood flow –> promotion of diuresis

Inhibitors: Aspirin, tNSAIDs, glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

COX-2: tissue locations, physiologic role, inhibitors?

A

Tissue locations: Kidneys, endothelial cells, uterine smooth muscle, ductus arteriosus

Physiologic role:
o KIDNEYS: up-regulated –> adaptation to stress via maintenance of renal blood flow
o ENDOTHELIAL CELLS: up-regulated by shear stress
• Vasodilation and anti-aggregatory platelet effect (PGI2) –> decrease platelet aggregation
o UTERINE SMOOTH MUSCLE: contributes to labor contractions near parturition
o DUCTUS ARTERIOSUS: maintenance of PDA via vasodilation
o Tissue damage –> pain, inflammation
o Hypothalamus –> fever

Inhibitors: Aspirin, tNSAIDs, acetaminophen (in CNS!), Celecoxib, glucocorticoids

If you inhibit COX-2, you’ll increase clotting, risk of MI, etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the effects of prostaglandins on vascular smooth muscle, platelets, GI tract smooth muscle and secretory cells, kidney cells, uterus, and inflammatory cells?

A

Vascular smooth muscle: prostaglandins vasodilate, TXA vasoconstricts

Platelets: pro-aggregatory effect (COX1) and anti-aggregatory effects (COX2)

GI tract: ↑ mucus/bicarb secretions, ↓ acid/pepsin secretion (cytoprotective); ↑ smooth muscle contractions

Kidney cells: ↑ renal blood flow (COX1), adaption to stress via maintenance of renal blood flow (COX2)

Uterus: ↑ smooth muscle contractions, contributes to labor contractions near parturition

Inflammatory cells: COX2 causes pain & inflammation via vasodilation, leukocyte infiltration

Common side effects:

  • GI ulceration, bleeding: COX1 in gastric cells
  • Increased bleeding risk: COX1 in platelets
  • Renal dysfunction: COX1 and COX2 in kidneys
  • Delay labor: COX2 in uterine smooth cells
  • Increased thrombotic events: COX2 in endothelial cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the effects of leukotrienes on inflammatory cell function and pulmonary/vascular smooth muscle?

A

Leukotrienes lead to increased vascular permeability, vasoconstriction, and bronchospasm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the functional interactions of prostacyclin and thromboxane A2 with relation to physiologic effects on vascular smooth muscle and platelets?

A

Prostacyclin (PGI2) causes vasodilation & inhibits platelet aggregation.
Thromboxane A2 (TXA2) causes vasoconstriction & promotes platelet aggregation.
Soooooo… they’re opposites.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Compare and contrast the effects of aspirin, acetaminophen, NSAIDs, and COX-2 selective inhibitors on the cyclooxygenase enzymes 1 and 2 as the relation to therapeutic uses and adverse reactions.

A

Therapeutic uses:
- Analgesia: COX-2 at sites of tissue injury
o Intermediate doses (prn)

  • Antipyrectic: COX-2 in hypothalamus
    o Intermediate doses (prn)
  • Anti-inflammatory: COX-2 at sites of tissue injury
    o High doses
  • Antithrombotic: COX1 in platelets
    o Low doses – daily

Aspirin: irreversible inhibitions of COX-1 and COX-2

tNSAIDs: reversible inhibition of COX-2 and COX-2

Acetaminophen: reversible inhibition of CNS COX-2

Celecoxib: reversible selective inhibition of COX-2

NSAIDs that inhibit COX-2 would result in:
- Therapeutic actions: relief of pain - reduction of fever - reduction of inflammation
- Potential side effects: acute renal failure - thrombotic events (COX-2 selective agents) -
prolonged gestation

NSAIDs that inhibit COX-1 would result in:
- Potential side effects: GI ulceration - prolonged bleeding time - acute renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the mechanism whereby low-dose, but not high-dose, aspirin is able to exert an anti-thrombotic / cardioprotective effect (is COX-1 selective)

A

Platelets don’t have nuclei, whereas endothelial cells do. If you wipe out COX-1 irreversibly in a platelet, you need to make more platelets to make COX-1 –> make TXA2 –> clotting. If you wipe it out in an endothelial cells, nuclei will just upregulate COX-2.

Acetylsalicylic acid is highest in concentration in portal vein, just prior to being broken down by esterases in liver. In this location, a constant concentration of acetylsalicylic acid (daily low dose) will see ALL platelets, only some EC.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ASPIRIN
Therapeutic uses? Metabolism and excretion? Common side effects at therapeutic doses? Overdose toxicities and their treatment? Contraindications to use? Drug-drug interactions?

A

Therapeutic uses: analgesic effects (pain of inflammatory origin), antipyretic effects, anti-inflammatory effects, anti-platelet effect

Metabolism and excretion: Acetylsalicylic acid rapidly hydrolyzed to salicylate by esterases in blood. Salicylate then more slowly eliminated by glycine or glucuronide conjugations. Excreted into urine.

Common side effects at therapeutic doses: gastric irritation, bleeding, renal dysfunction, delay onset of labor, Reye’s syndrome

Overdose toxicities and their treatment: hyperventilation and respiratory alkalosis (6-10); fever, dehydration, and metabolic acidosis (10-20 g); shock, coma, resp failure, death. Treatment: Na bicarb, cooling blankets, gastric lavage & charcoal

Contraindications to use: ulcer patients, patients on oral anticoagulants, use caution w/ chronic renal insufficiency (elderly), avoid during pregnancy, avoid in children s syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ACETAMINOPHEN
Therapeutic uses? Metabolism and excretion? Common side effects at therapeutic doses? Overdose toxicities and their treatment? Contraindications to use? Drug-drug interactions?

A

Therapeutic uses: mild to mod pain, antipyretic, some use in osteoarthritis. NOT ANTI-INFLAMMATORY

Metabolism and excretion: metabolized to sulfate and glucuronide (phase II conj). Small % metabolized to hepatotoxic metabolite (P2E1) - detoxified by GSH conjugation (phase II)

Common side effects at therapeutic doses: little or no effects on peripheral COX 1-2. Hepatotoxicity major concern!!!

Overdose toxicities and their treatment:

Contraindications to use:

Drug-drug interactions: w/ alcohol :(

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
TRAD NSAIDS (ibuprofen/naproxen/ketorolac)
Therapeutic uses? Metabolism and excretion? Common side effects at therapeutic doses? Overdose toxicities and their treatment? Contraindications to use? Drug-drug interactions?
A

Therapeutic uses: analgesic (also together with opioids for post-op pain), antipyretic, anti-inflammatory

Common side effects at therapeutic doses: better tolerated; safer in overdose. GI irritation, bleeding transient and reversible. Safety in pregnancy not established.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CELECOXIB
Therapeutic uses? Metabolism and excretion? Common side effects at therapeutic doses? Overdose toxicities and their treatment? Contraindications to use? Drug-drug interactions?

A

Therapeutic uses: 5-7 fold selectivity for COX-2 over COX-1. Analgesic, antipyretic, and anti-inflammatory effects
Indicated for INFLAMMATORY CONDITIONS: RA, ankylosing spondylitis, acute pain, primary dysmenorrhea

Metabolism and excretion: metabolized by the liver with metabolites eliminated by renal excretion

Common side effects at therapeutic doses: inhibit uterine labor contractions; fewer ulcers than other NSAIDs; renal side effects same as NSAIDs; no prolonged bleeding time

IMPORTANT: increased risk of CV thrombotic events = selectively inhibit anti-aggregatory PGI2 in EC

Overdose toxicities and their treatment:

Contraindications to use: Benefits outweigh risks in pts who cannot use NSAIDs b/c of GI side effects. Risks outweigh benefits in pts with underlying CV disorders*

Drug-drug interactions: possible inhibition of warfarin metabolism –> increased bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the regulation of glucocorticoid secretion by the hypothalamic-pituitary-adrenal gland axis

A

From hypothalamus, corticotropoid-releasing hormone (CRH) –> causes corticotropoid (ACTH) to be released from anterior pituitary –> causes release of adrenal hormones cortisol [GC] and aldosterone [MC]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the metabolic and mineralocorticoid effects associated with glucocorticoids and explain how these effects can result in serious adverse effects when they are used as pharmacotherapeutic agents

A

*GC metabolic effects:
CARBOHYDRATES: ↑ gluconeogenesis –> ↑ blood glucose (excess = diabetes-like state)
PROTEINS: ↓ protein synthesis –> ↑ AA to glucose (excess = muscle wasting, CT/skin atrophy)
FAT: ↑ lipolysis (periph) –> ↑ free fatty acids (excess = ↑ lipogenesis centrally via insulin –> obesity)

Excess = iatrogenic Cushing’s Disease

*MC metabolic effects (aldosterone):
↑ Na+ reabsorption at kidney –> ↑ blood volume and BP
(excess = fluid retention, HTN, hypoK, metabolic alkalosis)

[GC side effects]:
adrenal gland suppression
iatrogenic Cushing’s disease

[MC side effects]:
HTN
Hypokalemia
metabolic alkalosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Explain the rationale for alternate day therapy and tapered withdrawal following chronic therapy with glucocorticoids

A

Chronic therapy = suppression of adrenal gland & release of ACTH.
If you taper, you give the adrenal glands time to recover.

Also, to prevent the disease from flaring back up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the mechanisms of the anti-inflammatory and and immunosuppressive effects of GCs?

A

(1) Reduced vasodilation; ↓ fluid exudation
(2) overall ↓ in accumulation & activation of inflammatory and immune cells
(3) decrease in infl/imm mediator synthesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Prednisone

A

Needs to be activated by liver into prednisolone!

GC:MC 5:1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Dosing considerations of GCs

A

Most potent: Dexa
Moderately potent: Methylpred, Triam
Least potent: Hydrocortisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Triamcinolone

A

Potent, excellent topical activity

No MC action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Dexamethasone

A

Most potent anti-inflammatory agent

Use: cerebral edema; chemotherapy-induced vomiting

Minimal MC action; greatest suppression of ACTH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Compare and contrast the relative salt-retaining vs anti-inflammatory activities vs ACTH suppression and routes of administration for the drugs below.

A

Salt-retaining:
Methylpred, Triam, and Dexa are all NOT s-r

Anti-inflammatory:

ACTH suppression:

Routes of administration:
Topical = hydrocortisone, Triam, & Dexa
Oral ONLY = prednisone, Fludro (need to be metabolized by liver)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Methylprednisolone

A

IV for steroid burst

Minimal MC action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Toxicities (acute vs. chronic vs. withdrawal)

A

ACUTE
[MC]: salt + water retention, edema, HTN, hypoK
[GC]: glucose intolerance in diabetics; mood changes, insomnia, GI upset

CHRONIC
[GC]: Cushing's syndrome (hyperglycemia, protein/muscle loss, lipid deposition/weight gain, diabetes-like state
Adrenal suppression --> loss of hormones
Mood disturbances --> initial euphoria, then psychic letdown or psychosis (rarely) when dose reduced
Impaired wound healing
Increased susceptibility to infection 
Osteoporosis 
Posterior capsular cataracts
Skin atrophy, loss of collagen support
Growth retardation in children 
Peptic ulceration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
What is the difference between exertional heat stroke and classic heat stroke?
Exertional heat stroke: hot, dry skin, usually (not always) there is cessation of sweating. Usually lactic acidosis. May lead to rhabdomyolysis (breakdown of skeletal muscle fibers), AKI, disseminated intravascular coagulation (DIC), multi organ failure. Classic heat stroke - young, elderly, obese in hot humid weather. Hot, dry skin. No lactic acidosis, but respiratory alkalosis. Hypotension, coma. AKI and DIC are very uncommon.
26
How do you distinguish alcoholic hepatitis morphologically?
In alcoholic hepatitis, we see swollen hepatocytes, death of occasional hepatocytes, an infiltrate of PMNs, and a ropy, eosinophilic material within the cytoplasm of some hepatocytes called “alcoholic hyaline” (representing aggregates of cytokeratin filaments).
27
How do free radicals arise?
Oxygen therapy Acute inflammation (PMNs have myeloperoxidases) Reperfusion (Xanthine oxidase, which is produced from proteolysis during hypoxia)
28
How does the body get rid of free radicals?
Superoxide dismutase (SOD) gets rid of superoxide (O2-) by converting to hydrogen peroxide Glutathione peroxidase is a very important enzyme – catalyzes: o GSH is a reducing agent in the cell that gets rid of radicals Antioxidants (uric acid, Vitamin E) can eliminate radicals
29
What type of metaplasia occurs in the esophagus after chronic gastric acid exposure?
Chronic reflux esophagitis leads to replacement of the stratified squamous epithelium along the distal esophagus by a columnar type of intestinal epithelium. Stratified squamous --> columnar
30
What type of metaplasia occurs in the lungs after chronic smoke exposure?
Replacement of the pseudostratified columnar epithelium of the bronchus by stratified squamous epithelium Columnar --> stratified squamous
31
What are the cell membrane changes that occur during injury?
↓ Na pump ↑ influx of Ca and Na ions & water ↑ efflux of K ions leads to cellular swelling
32
Coagulative necrosis
Dead cell remains a ghost-like remnant of its former self – classically seen in an MI Pyknosis Nucleus is intensely dark staining and shrunken --> seen in a necrotic (dead) cell Karyorrhexis Fragmentation of pyknotic nucleus Karyolysis Extensive hydrolysis of the pyknotic nucleus with loss of staining. Represents breakdown of the denatured chromatin.
33
Liquefactive necrosis
The dead cell undergoes extensive autolysis, caused by the release of lysosomal hydrolases (proteinases, DNases, RNases, lipases, etc.) Seen classically in the brain and spleen following infarction All of the dead tissue is liquefied
34
Caseous necrosis
Seen in TB (mycobacterium tuberculosis) Type of necrosis seen within infected tissues characterized as soft, friable, whitish-grey (resembles the milk protein casein)
35
Fat necrosis
Leakage of lipases from dead cells attack triglycerides in surrounding fat tissue and generate free fatty acids and calcium soaps. These soaps have a chalky-white appearance Seen in the pancreas following acute inflammation
36
What is a transudate?
Ultra-filtrate of plasma Etiology = ↑ hydrostatic pressure/reduced oncotic pressure **More glucose**
37
What is an exudate?
Protein-rich content; cells Protein >1.02 g/mL, fibrin Etiology = inflammation Less glucose = if you have a bacterial infection, the bacteria will use up a lot of that glucose, so there’ll be less in the exudate than transudate Leukocytes
38
What are the cells of acute & chronic inflammation?
ACUTE: PMNs CHRONIC: Macrophages, lymphocytes, plasma cells, eosinophils, BOTH: Mast cells/basophils, platelets
39
What is a granuloma?
A group of giant cells that have come together
40
What is hemachromatosis?
Too much iron in the body = iron overload The organs involved are the liver, heart, pancreas, pituitary, joints, and skin Excess iron is hazardous, because it produces free radical formation
41
What are sentinel cells?
Native macrophages within tissues
42
Fibrinopurulent exudate
Anywhere, but usually in non-confined space PMNS predominate Infectious: bacterial, fungal
43
Abscess
Within parenchyma/confined space (brain, lung, liver). PMNs predominate Infectious: bacterial, fungal
44
Empyema
Within an anatomic cavity or space: pleural, subdural, etc. Early PMNs, then macrophages & lymphocytes Infectious: bacterial & fungal
45
Cellulitis
Skin (epidermis, dermis, subq) Fascia/deep CT Infectious (bacterial: Staph, Strep) Inflammatory Neutrophils early... mononuclear later on Into fascia: necrotizing fasciitis
46
Granuloma
Usually within parenchyma (lung, lymph node, liver, spleen) Rounded, nodular appearance. Often mineralized, so visible on CT/X-ray Macrophages, lymphocytes, and plasma cells
47
What is cholelithiasis?
Gallstone(s)
48
What is cholecystitis?
Inflammation of the gall bladder
49
What is choledocholithiasis?
Gallstone(s) in the common bile duct
50
What is the process of collateral damage in inflammation? What are some clinical examples?
Collateral damage occurs because of: - Neutrophils that die 1-2 days after migration --> cellular contents released - Macrophages - Inflammatory mediators (reactive O2 species, NO) - Enzymes, proteases, acid hydrolases from immune cells Clinical examples: - Loss of septae in pneumonia – PMNs chewed their way through the CT - Rheumatoid arthritis --> chronic inflammatory cells attack synovial joint space; erode through cartilage
51
Which chemical mediators of inflammation are made pre-formed in secretory granules?
Histamine, serotonin, and lysosomal enzymes
52
Which chemical mediators are newly-synthesized?
Prostaglandins, leukotrienes, platelet-activating factors, activated O2 species, NO, and cytokines
53
Which chemical mediators of inflammation are made by cells?
The liver makes Factor XII (Hageman) factor --> bradykinin, coagulation; activates complement
54
Which cells make histamines?
Mast cells, basophils, platelets
55
Which cells make serotonin?
Platelets
56
Which cells make lysosomal enzymes?
Neutrophils, macrophages
57
What does hydrostatic pressure do in maintaining body fluid balance?
Hydrostatic pressure “pushes” fluid from the capillary into the interstitial space at the arterial end.
58
What does oncotic pressure do in maintaining body fluid balance?
Loss of fluid at the arterial end then increases the plasma protein concentration (oncotic pressure), so fluid is “pulled” back into the capillary at the venous end to balance the protein concentration.
59
What is edema?
Extravasion (leakage) of fluid into tissues
60
What is effusion?
Extravasion of fluid into body cavities (e.g., ascites)
61
What is hyperemia?
An active ↑ in blood flow due to arteriolar dilation Serves normal physiologic purposes, such as bringing inflammatory mediators into areas of tissue damage Provides oxygen to exercising skeletal muscle Causes red color (erythema) in the tissues due to increased mass of oxygenated RBCs
62
What is congestion?
A pathologic accumulation of blood due to impaired outflow of venous blood Either too much pressure for the fluid to flow, or there’s a physical obstruction Congested tissue has a red-blue color due to accumulation of deoxygenated blood May have ↑ hydrostatic pressure
63
What are petechiae?
Capillaries that have broken and blood that has moved out into surrounding tissue --> red spots 1-2 mm in diameter
64
What is a hematoma?
Bleeding into an enclosed space (within tissue)
65
What is purpura?
Spots from bleeding >3 mm
66
What are ecchymoses?
Bruises --> spots from bleeding 1-2+ cm
67
What are the key factors that are involved in thrombosis? (Virchow's Triad)
(1) Endothelial injury (hypercholesterolemia, inflammation) (2) Hypercoagulability (inherited or acquired) (3) Abnormal blood flow (stasis, turbulence, etc.)
68
What is the difference between a thrombus and an embolus?
Thrombus: crazy clotting ATTACHED to a vessel wall Embolus: Free-floating, intravascular mass of gas, liquid, or solid Thromboembolus = clot that broke free!
69
Left vs. right emboli?
Emboli in the venous/right sided system most commonly lodge in the lungs. Emboli in the arterial/left sided system can affect any organ, but most commonly travel to the legs or brain.
70
Red infarcts
HEMORRHAGIC Venous insufficiency/occlusion Can occur after an arterial occlusion if blood flow is subsequently reestablished and damage vessels allow movement of blood into the necrotic area Dual blood supply YES to reperfusion Loose tissues --> permit movement of blood from adjacent areas into necrotic area Organs: lung, liver, intestine
71
White infarcts
ANEMIC ``` Arterial insufficiency Single blood supply NO to reperfusion Dense tissue type Organs: heart, kidney, spleen ```
72
Cardiogenic shock & hypovolemic shock
Cardiogenic: Failure of the heart to pump an adequate amount of blood and/or to perfuse tissues adequately Hypovolemic: Not enough blood volume to perfuse all tissues, and so cardiac output decreases because there is low blood volume returning to the heart Both result in: Low blood pressure + low cardiac output --> vasoconstriction, ↑ heart rate, and renal conservation of fluid Patients present with cool skin, pallor, tachycardia, and ↓ urine output
73
Septic shock
A subtype of shock due to SIRS--> occurs when microbial infections cause high levels of inflammatory mediators in the blood everywhere in the body Leads to widespread arterial vasodilation, vascular leakage, and venous blood pooling --> Results in hypotension and ↓ tissue perfusion Patients present with warm, flushed skin, hypotension, edema, increased HR, and fever
74
5-Fluorouracil (5-FU)
Inhibits DNA synthesis via TS (thymidylate synthase)
75
Methotrexate
Used for hematological malignancies Reversible, competitive inhibitor of DHFR - required for synthesis of purine nucleotides
76
Platinum compounds
Cross-link DNA (usually CpG) High nephrotoxicity. Ototoxicity, neurotoxicity. Inactivation via reaction with GSH
77
Alkylating agents
Produce inter-strand crosslinks in DNA Inactivated via GSH. Cells with high levels of ALDH are resistant to drug. Gonadal toxicity. Increased risk of later carcinogenesis.
78
Topoisomerase interacting agents
The agents stabilize topoisomerase-DNA interactions, making the cell unable to re-ligate the DNA. Resistant: increased drug efflux, mutations in topoisomerases. Cardiotoxicity (iron chelators may provide protection). Secondary malignancies, especially AML.
79
Antimicrotubule agents
Bind to tubulin --> depolymerization --> activates apoptosis Neurotoxicity, myelosuppression, neutropenia.
80
Hormonal agents
Treats hormonally-response cancers (breast, endometrial, prostate) Tamoxifen = estrogen receptor inhibitor